New horizons in hCG detection.
The advent of high technology in the field of hCG measurement has created a greater requirement for high expertise in the analysis and evaluation of hCG levels, particularly low-positive levels, and for the concomitant clinical management of the patient. This implies an imperative to treat trophoblastic disease patients in trophoblast disease referral centers.
D000911:Antibodies, Monoclonal; D006063:Chorionic Gonadotropin / Q000032:analysis* / Q000096:biosynthesis / Q000276:immunology; D018997:Chorionic Gonadotropin, beta Subunit, Human; D005260:Female; D006729:Hormones, Ectopic / Q000032:analysis; D006801:Humans; D007118:Immunoassay; D010446:Peptide Fragments / Q000032:analysis; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000032:analysis; D002583:Uterine Cervical Neoplasms / Q000032:analysis; D014594:Uterine Neoplasms / Q000032:analysis
D000911:Antibodies, Monoclonal; D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D006729:Hormones, Ectopic; D010446:Peptide Fragments